Schizophrenia pp 163-196 | Cite as

Treatments

Guidelines and Modalities
  • John S. Strauss
  • William T. CarpenterJr.
Part of the Critical Issues in Psychiatry book series (CIPS)

Abstract

Treatment for schizophrenia has never been satisfactory, and this is still true today even though the clinician can now draw upon a number of available treatment methods. Nonetheless, very significant progress has been accomplished during the middle third of the twentieth Century, and the degree of hopelessness and therapeutic nihilism previously associated with the diagnosis of schizophrenia is no longer warranted.

Keywords

Antipsychotic Drug Negative Symptom Schizophrenic Patient Family Therapy Antipsychotic Medication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Recommended Reading

  1. Davis, J., Schaffer, C, Killian, G., Kinard, C, and Chan, C. Important issues in the drug treatment of schizophrenia. Schizophrenia Bulletin, 1980, 6: 70–87.PubMedCrossRefGoogle Scholar
  2. May, P. Schizophrenia: Evaluation of treatment. In: Comprehensive Textbook of Psychiatry, Vol. 2, Freedman, A., Kaplan, H., and Sadock, B. (eds.). Baltimore: Williams and Wilkins, 1975, 955–982.Google Scholar
  3. Mosher, L., and Gunderson, J. Group, family, milieu, and community support systems treatment for schizophrenia. In: Disorders of the schizophrenic syndrome, Bellak, L. New York: Basic Books, 1979, 399–452.Google Scholar
  4. Scott, R. D., and Ashworth, P. The shadow of the ancestor. British Journal of Medical Psychology, 1969, 42: 13–32.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Barton, R. Institutional neurosis. Bristol: Wright, 1959.Google Scholar
  2. 2.
    Wing, J., and Brown, G. Institutionalism and schizophrenia. Cambridge: Cambridge University Press, 1970.CrossRefGoogle Scholar
  3. 3.
    Hogarty, G., Goldberg, S., Schooler, N., Ulrich, R. et al. Drugs and sociotherapy in the aftercare of schizophrenic patients. Archives of General Psychiatry, 1974, 131: 603–608.CrossRefGoogle Scholar
  4. 4.
    Clausen, J. The impact of mental illness: A 20-year follow-up. In: Life history research in psychopathology, Vol. 4, Wirt, R. D., Winokur, G., and Roff, M. (eds.). Minneapolis: University of Minnesota Press, 1976, 270–289.Google Scholar
  5. 5.
    Lamb, H., and Goertzel, V. Discharged mental patients—are they really in the community? Archives of General Psychiatry, 1971, 24: 29–34.PubMedCrossRefGoogle Scholar
  6. 6.
    Glick, I., Hargreaves, W., Raskin, M., et al. Short versus long hospitalization. II. Results for schizophrenic inpatients. American Journal of Psychiatry, 1975, 132: 385–390.PubMedGoogle Scholar
  7. 7.
    Phipps, L. The impact of psychiatric hospitalization on the spouse of the identified patient. Unpublished master’s thesis, School of Nursing, University of Rochester, Rochester, NY, 1976.Google Scholar
  8. 8.
    Mosher, L., and Keith, S. Research on the psychosocial treatment of schizophrenia: A summary report. American Journal of Psychiatry, 1979, 136: 623–631.PubMedGoogle Scholar
  9. 9.
    Strauss, J. S., Kokes, R. F., Ritzler, B. A., Harder, D. W., and VanOrd, A. Patterns of disorder in first admission psychiatric patients. Journal of Nervous and Mental Disease, 1978, 166(9): 611–625.PubMedCrossRefGoogle Scholar
  10. 10.
    Heinrichs, D.W., and Carpenter, W. T., Jr. The efficacy of individual psychotherapy: A perspective and review emphasizing controlled outcome studies. In: The American Handbook of Psychiatry, Vol. 7, Arieti, S., and Brodie, H. K. (eds.). New York: Basic Books in press.Google Scholar
  11. 11.
    McGlashan, T. H., and Carpenter, W. T., Jr. Affective symptoms and the diagnosis of schizophrenia. Schizophrenia Bulletin, 1979, 5(4): 547–553.PubMedCrossRefGoogle Scholar
  12. 12.
    Carpenter, W. T., Jr., and Heinrichs, D. The role for psychodynamic psychiatry in the treatment of schizophrenic patients. In: Psychotherapy of Schizophrenia, Strauss, J. S., Bowers, M., Downey, T. W. et al. (eds.). New York: Plenum, 1980.Google Scholar
  13. 13.
    Bleuler, M. The schizophrenic disorders: Long-term patient and family studies. Translated by S. M. Clemens. New Haven: Yale University Press, 1978.Google Scholar
  14. 14.
    Ciompi, L. The natural history of schizophrenia in the long term. British Journal of Psychiatry, 1980, 136: 413–420.PubMedCrossRefGoogle Scholar
  15. 15.
    Strauss, J. S., Loevsky, L., Glazer, W., and Leaf, P. Organizing the complexities of schizophrenia. Journal of Nervous and Mental Disease, in press.Google Scholar
  16. 16.
    O’Brien, C. Group therapy for schizophrenia. Schizophrenia Bulletin, 1975, 13: 119–130.PubMedCrossRefGoogle Scholar
  17. 17.
    Vaughn, C, and Leff, J. The influence of family and social factors on the course of psychiatric illness. British Journal of Psychiatry, 1976, 139: 125–137.CrossRefGoogle Scholar
  18. 18.
    Mosher, L., and Gunderson, G. Group, family, milieu and community support systems treatment for schizophrenia. In: Disorders of the schizophrenic syndrome, Bellak, L. New York: Basic Books, 1979, 399–452.Google Scholar
  19. 19.
    Goldstein, M. J., Rodnick, E. H., Evans, J. R., May, R. A., and Steinberg, M. R. Drug and family therapy in the aftercare of acute schizophrenics. Archives of General Psychiatry, 1978, 35: 1169–1177.PubMedCrossRefGoogle Scholar
  20. 20.
    Paul G. Comprehensive psychosocial treatment: Beyond traditional psychotherapy. In: The psychotherapy of schizophrenia, Strauss, J. S., Bowers, M., Downey, T. W. et al. (eds.). New York: Plenum, 1980.Google Scholar
  21. 21.
    Liberman, R. P., Wallace, C. J., Vaughn, C. E. et al. Social and family factors in the course of schizophrenia: Toward an interpersonal problem-solving therapy for schizophrenics and their families. In: The psychotherapy of schizophrenia, Strauss, J. S., Bowers, M., Downey, T. W. et al. (eds.). New York: Plenum, 1980.Google Scholar
  22. 22.
    Davis, J., Schaffer, C, Killian, G., Kinard, C, and Chan, C. Important issues in the drug treatment of schizophrenia. Schizophrenia Bulletin, 1980, 6: 70–87.PubMedCrossRefGoogle Scholar
  23. 23.
    Hogarty, G. E., Goldberg, S., and Schooler, N. Drugs and sociotherapy in the aftercare of schizophrenia: A review. In: Drugs in combination with other therapies, Greenblatt, M. (ed.). New York: Grune & Stratton, 1975.Google Scholar
  24. 24.
    Crane, G. E. Risks of long-term therapy with neuroleptic drugs. In: Antipsychotic drugs: Pharmacodynamics and pharmacokinetics, Wenner-Gren International Symposium Series, Vol. 25, Unvas, B., and Zotterman, Y. (eds.). Elmsford, NY: Pergamon Press, 1976.Google Scholar
  25. 25.
    Gardos, G., and Cole, J. O. Overview: Public health issues in tardive dyskinesia. American Journal of Psychiatry, 1980, 137: 776–781.PubMedGoogle Scholar
  26. 26.
    Carpenter, W. T., Jr., and Rudo, A. Tardive dyskinesia: A major risk of neuroleptic drugs. Behavioral Medicine, July, 1979, 33–37.Google Scholar
  27. 27.
    Davis, K., Berger, P., and Hollister, L. Choline for tardive dyskinesia. The New England Journal of Medicine, 1975, 293: 152.PubMedGoogle Scholar
  28. 28.
    Gelenberg, A. J., Doller-Wojcik, J. E., and Growdon, J. H. Choline and lecithin in the treatment of tardive dyskinesia: Preliminary results from a pilot study. American Journal of Psychiatry, 1979, 136: 772–776.PubMedGoogle Scholar
  29. 29.
    Carpenter, W. T., Jr., Rey, A. C, and Stephens, J. H. Covert dyskinesia in ambulatory schizophrenia. The Lancet, July 26, 1980, 8187: 212–213.CrossRefGoogle Scholar
  30. 30.
    Gardos, G., and Cole, J. O. Maintenance antipsychotic therapy: Is the cure worse than the disease? American Journal of Psychiatry, 1976, 133: 32–36.PubMedGoogle Scholar
  31. 31.
    Monroe, R. R. Episodic behavioral disorders. Cambridge: Harvard University Press, 1970.Google Scholar
  32. 32.
    May, P., and Tuma, H. Follow-up study of the results of treatment of schizophrenia. In: Evaluation of psychological therapies, Spitzer, R., and Klein, D. (eds.). Baltimore: Johns Hopkins University Press, 1976, 256–284.Google Scholar
  33. 33.
    Ban, T. A., and Lehmann, H. E. Nicotinic acid in the treatment of schizophrenia, Part 2. Canadian Psychiatric Association Journal, 1976, 20: 103–112.Google Scholar
  34. 34.
    Wagemaker, H., and Cade, R. The use of hemodialysis in chronic schizophrenia. American Journal of Psychiatry, 1977, 134: 684–685.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • John S. Strauss
    • 1
  • William T. CarpenterJr.
    • 2
  1. 1.Yale University School of MedicineNew HavenUSA
  2. 2.Maryland Psychiatric Research CenterUniversity of Maryland School of MedicineBaltimoreUSA

Personalised recommendations